000 01523 a2200433 4500
005 20250516024615.0
264 0 _c20111221
008 201112s 0 0 eng d
022 _a1533-712X
024 7 _a10.1097/JCP.0b013e31820fcea3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFernandez-Egea, Emilio
245 0 0 _aMetabolic effects of olanzapine in patients with newly diagnosed psychosis.
_h[electronic resource]
260 _bJournal of clinical psychopharmacology
_cApr 2011
300 _a154-9 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aBenzodiazepines
_xadverse effects
650 0 4 _aBlood Glucose
_xdrug effects
650 0 4 _aCohort Studies
650 0 4 _aDiabetes Mellitus, Type 2
_xblood
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInsulin
_xblood
650 0 4 _aInterleukin-6
_xblood
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOlanzapine
650 0 4 _aPredictive Value of Tests
650 0 4 _aPsychotic Disorders
_xblood
650 0 4 _aYoung Adult
700 1 _aMiller, Brian
700 1 _aGarcia-Rizo, Clemente
700 1 _aBernardo, Miguel
700 1 _aKirkpatrick, Brian
773 0 _tJournal of clinical psychopharmacology
_gvol. 31
_gno. 2
_gp. 154-9
856 4 0 _uhttps://doi.org/10.1097/JCP.0b013e31820fcea3
_zAvailable from publisher's website
999 _c20622402
_d20622402